These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 1156039)
1. Comparison between the effects of ST 600 and catapres. Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039 [TBL] [Abstract][Full Text] [Related]
2. Comparison between the effects of ST 600 and clonidine. Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909 [TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and endocrine changes during anti-hypertensive treatment with clonidine and its derivative St 600. Kho TL; Zaal GA; Wester A; de Leeuw PW; Birkenhäger WH Clin Sci Mol Med Suppl; 1976 Dec; 3():641s-643s. PubMed ID: 1071697 [TBL] [Abstract][Full Text] [Related]
4. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs. Maxwell GM Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):7-14. PubMed ID: 5350786 [No Abstract] [Full Text] [Related]
5. Hemodynamic and plasma renin effects of propranolol in essential hypertension. Mookherjee S; Eich RH; Obeid AI; Smulyan H Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147 [TBL] [Abstract][Full Text] [Related]
6. [A new antihypertensive imidazoline derivative (St 600, Fluoronidine): I. Haemodynamic investigations at rest and during exercise (author's transl)]. Djawan S; Mlezoch J; Niederberger M; Penner E; Grabner G Wien Klin Wochenschr; 1976 Mar; 88(6):199-206. PubMed ID: 973381 [TBL] [Abstract][Full Text] [Related]
7. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)]. Levenson J; Simon A; Temmar M; Safar M Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis. Cosnier D; Labrid C; Rispat G; Streichenberger G Arzneimittelforschung; 1975 Nov; 25(11):1802-6. PubMed ID: 1243090 [TBL] [Abstract][Full Text] [Related]
9. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation. Koch G Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382 [No Abstract] [Full Text] [Related]
11. [Hemodynamic effects of ST 155, 2-(2,6 dichlorophenylamino)-2 imidazoline hydrochloride, in hypertensive dogs]. Laubie M; Schmitt H Arch Int Pharmacodyn Ther; 1969 May; 179(1):23-5. PubMed ID: 5348396 [No Abstract] [Full Text] [Related]
12. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension. Ando K; Noda H; Ogata E; Fujita T J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633 [TBL] [Abstract][Full Text] [Related]
13. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension. O'Connor DT; Mosley CA; Cervenka J; Bernstein KN J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882 [TBL] [Abstract][Full Text] [Related]
14. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension. Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
16. Radionuclide techniques in studies of cardiac performance and circulatory changes during antihypertensive treatment. Falch DK J Oslo City Hosp; 1980; 30(9-10):113-36. PubMed ID: 7003079 [No Abstract] [Full Text] [Related]
17. Haemodynamic and endocrinological profile of essential hypertension. de Leeuw PW; Kho TL; Falke HE; Birkenhäger WH; Wester A Acta Med Scand Suppl; 1978; 622():5-86. PubMed ID: 282795 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155). Onesti G; Schwartz AB; Kim KE; Swartz C; Brest AN Circulation; 1969 Feb; 39(2):219-28. PubMed ID: 4884576 [No Abstract] [Full Text] [Related]
19. Effects of timolol on blood pressure, systemic hemodynamics, plasma renin activity, and glomerular filtration rate in patients with essential hypertension. Valvo E; Gammaro L; Tessitore N; Fabris A; Ortalda V; Bedogna V; Maschio G Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):156-61. PubMed ID: 6370874 [TBL] [Abstract][Full Text] [Related]
20. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension. London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]